These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25594496)

  • 21. Effects of argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding.
    Sun X; Chen Y; Xiao Q; Wang Y; Zhou J; Ma Z; Xiang J; Chen X
    Nephrol Dial Transplant; 2011 Sep; 26(9):2954-9. PubMed ID: 21303963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
    Hellwig TR; Peitz GJ; Gulseth MP
    Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia.
    Keyl C; Zimmer E; Bek MJ; Wiessner M; Trenk D
    Thromb Haemost; 2016 Jun; 115(6):1081-9. PubMed ID: 26792118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case series describing the use of argatroban in patients on extracorporeal circulation.
    Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G
    ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.
    Guy S; Kitchen S; Maclean R; Van Veen JJ
    Int J Lab Hematol; 2015 Dec; 37(6):834-43. PubMed ID: 26305560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticoagulant efficacy and safety of argatroban for patients undergoing elective percutaneous coronary intervention].
    Tian F; Yu H; Chen YD; Liu HB; Guo J; Sun ZJ; Jin QH; Yan F; Ma YL; Gu XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):480-3. PubMed ID: 24113039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
    Young G; Boshkov LK; Sullivan JE; Raffini LJ; Cox DS; Boyle DA; Kallender H; Tarka EA; Soffer J; Hursting MJ
    Pediatr Blood Cancer; 2011 Jul; 56(7):1103-9. PubMed ID: 21488155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting.
    Klingele M; Enkel J; Speer T; Bomberg H; Baerens L; Schäfers HJ
    J Cardiothorac Surg; 2020 Jan; 15(1):27. PubMed ID: 31992340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of intracardiac thrombi with argatroban.
    Niedeggen A; Lejczyk J; Kroner S; Stortz C; Reith S; Janssens U
    Acute Card Care; 2008; 10(4):221-6. PubMed ID: 18720086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent argatroban resistance in a patient with elevated factor VIII levels.
    Kennedy DM; Alaniz C
    Ann Pharmacother; 2013; 47(7-8):e29. PubMed ID: 23737512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects.
    Swan SK; St Peter JV; Lambrecht LJ; Hursting MJ
    Pharmacotherapy; 2000 Jul; 20(7):756-70. PubMed ID: 10907966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
    Tang IY; Cox DS; Patel K; Reddy BV; Nahlik L; Trevino S; Murray PT
    Ann Pharmacother; 2005 Feb; 39(2):231-6. PubMed ID: 15632219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.
    Begelman SM; Baghdasarian SB; Singh IM; Militello MA; Hursting MJ; Bartholomew JR
    J Intensive Care Med; 2008; 23(5):313-20. PubMed ID: 18701526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
    Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.
    Smythe MA; Koerber JM; Forsyth LL; Priziola JL; Balasubramaniam M; Mattson JC
    Pharmacotherapy; 2009 Sep; 29(9):1073-81. PubMed ID: 19698012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.
    LaMonte MP; Brown PM; Hursting MJ
    Crit Care Med; 2004 Apr; 32(4):976-80. PubMed ID: 15071388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.
    Tardy-Poncet B; Nguyen P; Thiranos JC; Morange PE; Biron-Andréani C; Gruel Y; Morel J; Wynckel A; Grunebaum L; Villacorta-Torres J; Grosjean S; de Maistre E
    Crit Care; 2015 Nov; 19():396. PubMed ID: 26556106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.